Skip to Main Content

UCB to explore disease specific digital solutions with Medixine


UCB, a global biopharma company, started a project where they will develop and pilot disease specific connected care solutions. For this pilot, UCB chose Medixine as the platform and cloud solution. 

“Our choice was based on Medixine’s solution being flexible and easily configurable, offering a rich framework for connected devices and being well proven in big deployments internationally.” says Serkan Oray, Head of Devices, Packaging and Wearable Technologies  at UCB. 

“UCB’s knowledgeable team will put Medixine Suite into full and meaningful use, we are thrilled to be working together” says Tapio Jokinen, president of Medixine.

Read more about Medixine’s solution

Share in social media: